The Latin America, Middle East and Africa Protein Therapeutics Market would witness market growth of 10.2% CAGR during the forecast period (2022-2028).
Protein treatments can offer effective replacement therapy without the requirement for gene therapy that is not currently available for the majority of genetic illnesses, for diseases in which, a gene is mutated or deleted. Besides, protein therapies may develop clinically and receive FDA approval more quickly than small-molecule medications. Additionally, because proteins are distinctive in both structure and function, businesses can acquire extensive patent protection for protein treatments.
Nowadays, genetic engineering and recombinant DNA technology have been developed, due to which, a large range of human proteins can be produced. The market for therapeutic proteins has expanded to new levels as a result of this cutting-edge technology. Recombinant DNA technology has facilitated the production of protein therapies and is taking the place of conventional natural extraction techniques.
Moreover, because many of the therapeutic proteins are produced by the body naturally, these drugs are frequently well tolerated and less likely to trigger immunological reactions. Research and development of mammalian cell-based manufacturing methods are being driven by the increased demand for high-quality recombinant medicines in an effort to increase production yields.
The prevalence of metabolic disorders is very high in Africa. The constellation of risk factors for cardiovascular disease is known as metabolic syndrome. Contrary to what was once believed, metabolic syndrome is now common throughout Africa. The prevalence is rising and tends to do so as people get older. The shift from conventional African to western lifestyles is assumed to be the cause of the country's rising prevalence of metabolic syndrome. It is not just a problem for adults in Africa, but young people are also starting to experience it more frequently.
The Brazil market dominated the LAMEA Protein Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $7,974.1 million by 2028. The Argentina market would exhibit a CAGR of 10.8% during (2022 - 2028). Additionally, The UAE market would witness a CAGR of 9.9% during (2022 - 2028).
Based on Product, the market is segmented into Monoclonal Antibodies, Human Growth Hormone, Fusion Protein, Insulin, Erythropoietin, Interferon and Follicle Stimulating Hormone. Based on Application, the market is segmented into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Protein Therapeutics Market is Predict to reach $490.2 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Monoclonal Antibodies
- Human Growth Hormone
- Fusion Protein
- Insulin
- Erythropoietin
- Interferon
- Follicle Stimulating Hormone
By Application
- Metabolic Disorders
- Immunologic Disorders
- Hematological Disorders
- Cancer
- Hormonal Disorders
- Genetic Disorders
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Baxter International, Inc.
- Amgen, Inc.
- F. Hoffmann-La Roche Ltd.
- Eli Lilly And Company
- Merck & Co., Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Pfizer, Inc.
- Novo Nordisk A/S
- Sanofi S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Protein Therapeutics Market, by Product
1.4.2 LAMEA Protein Therapeutics Market, by Application
1.4.3 LAMEA Protein Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Product Launches and Product Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
Chapter 4. LAMEA Protein Therapeutics Market by Product
4.1 LAMEA Monoclonal Antibodies Market by Country
4.2 LAMEA Human Growth Hormone Market by Country
4.3 LAMEA Fusion Protein Market by Country
4.4 LAMEA Insulin Market by Country
4.5 LAMEA Erythropoietin Market by Country
4.6 LAMEA Interferon Market by Country
4.7 LAMEA Follicle Stimulating Hormone Market by Country
Chapter 5. LAMEA Protein Therapeutics Market by Application
5.1 LAMEA Metabolic Disorders Market by Country
5.2 LAMEA Immunologic Disorders Market by Country
5.3 LAMEA Hematological Disorders Market by Country
5.4 LAMEA Cancer Market by Country
5.5 LAMEA Hormonal Disorders Market by Country
5.6 LAMEA Genetic Disorders Market by Country
5.7 LAMEA Others Market by Country
Chapter 6. LAMEA Protein Therapeutics Market by Country
6.1 Brazil Protein Therapeutics Market
6.1.1 Brazil Protein Therapeutics Market by Product
6.1.2 Brazil Protein Therapeutics Market by Application
6.2 Argentina Protein Therapeutics Market
6.2.1 Argentina Protein Therapeutics Market by Product
6.2.2 Argentina Protein Therapeutics Market by Application
6.3 UAE Protein Therapeutics Market
6.3.1 UAE Protein Therapeutics Market by Product
6.3.2 UAE Protein Therapeutics Market by Application
6.4 Saudi Arabia Protein Therapeutics Market
6.4.1 Saudi Arabia Protein Therapeutics Market by Product
6.4.2 Saudi Arabia Protein Therapeutics Market by Application
6.5 South Africa Protein Therapeutics Market
6.5.1 South Africa Protein Therapeutics Market by Product
6.5.2 South Africa Protein Therapeutics Market by Application
6.6 Nigeria Protein Therapeutics Market
6.6.1 Nigeria Protein Therapeutics Market by Product
6.6.2 Nigeria Protein Therapeutics Market by Application
6.7 Rest of LAMEA Protein Therapeutics Market
6.7.1 Rest of LAMEA Protein Therapeutics Market by Product
6.7.2 Rest of LAMEA Protein Therapeutics Market by Application
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.5.2 Acquisition and Mergers:
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Eli Lilly And Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 Johnson & Johnson (Janssen Global Services, LLC)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental &Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Novo Nordisk A/S
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
TABLE 1 LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Protein Therapeutics Market
TABLE 6 Trial and Approvals– Protein Therapeutics Market
TABLE 7 LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 8 LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 9 LAMEA Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Insulin Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Insulin Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Interferon Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Interferon Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 LAMEA Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 LAMEA Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 34 LAMEA Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 35 LAMEA Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 36 LAMEA Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 37 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 38 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 39 LAMEA Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 40 LAMEA Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 41 Brazil Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 42 Brazil Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 43 Brazil Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 44 Brazil Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 45 Brazil Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 46 Brazil Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 47 Argentina Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 48 Argentina Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 49 Argentina Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 50 Argentina Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 51 Argentina Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 52 Argentina Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 53 UAE Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 54 UAE Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 55 UAE Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 56 UAE Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 57 UAE Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 58 UAE Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 63 Saudi Arabia Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 Saudi Arabia Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 South Africa Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 66 South Africa Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 67 South Africa Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 68 South Africa Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 69 South Africa Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 70 South Africa Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 71 Nigeria Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 72 Nigeria Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 73 Nigeria Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 74 Nigeria Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 75 Nigeria Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 76 Nigeria Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 77 Rest of LAMEA Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 78 Rest of LAMEA Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 83 Key Information – Abbott Laboratories
TABLE 84 Key Information – Baxter International, Inc.
TABLE 85 Key Information – Amgen, Inc.
TABLE 86 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 87 Key Information – Eli Lilly And Company
TABLE 88 KEY INFORMATION - MERCK & CO., INC.
TABLE 89 Key information –Johnson & Johnson
TABLE 90 Key Information – Pfizer, Inc.
TABLE 91 Key information – Novo Nordisk A/S
TABLE 92 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Merck & Co., Inc.